Acute Prenatal Alcohol Exposure Potentiates Conotruncal Defects in the Setting of a Permissive Genetic Background
在允许的遗传背景下,急性产前酒精暴露会加剧圆锥干缺陷
基本信息
- 批准号:10731366
- 负责人:
- 金额:$ 5.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-18 至 2027-05-17
- 项目状态:未结题
- 来源:
- 关键词:AccidentsAcetylationAcidsAcuteAddressAlcohol consumptionAlcoholsApoptosisAutomobile DrivingAwarenessBiological AssayBiologyCardiacCementationChestChildhoodChronicClinicalClinical ResearchCollaborationsCongenital AbnormalityCongenital Heart DefectsCraniofacial AbnormalitiesCritical PathwaysDataDefectDevelopmentDiagnosisDoctor of MedicineDoctor of PhilosophyEducationEnsureEthanolExposure toFellowshipFetal Alcohol ExposureFetal Alcohol Spectrum DisorderFetal alcohol effectsFrequenciesGenesGeneticGenetic TranscriptionHeartHistologicHistonesHospitalizationIn VitroIncidenceIndividualInstitutionInterventionIntraperitoneal InjectionsInvestigationLigandsLiteratureLysineMentorshipMolecularMusMutationNational Institute on Alcohol Abuse and AlcoholismNatureNeonatal MortalityNeurologicOrganOrgan Culture TechniquesOrganogenesisParticipantPathway interactionsPatientsPopulationPregnancyPreventionPrincipal InvestigatorProliferatingRegression AnalysisRelative RisksReportingResearchReverse TranscriptionRiskRisk FactorsRoleSamplingSeveritiesSignal TransductionSiteSpecific qualifier valueSpecificityTeratogensTestingTherapeutic InterventionTimeTrainingValidationVariantWorkalcohol effectalcohol exposurealcohol riskbody systemcardiogenesisclinically relevantconotruncal heart defectcostdisorder preventiondrinkingepigenetic regulationgenome sequencinghistone acetyltransferasehuman studyin vivoinhibitormalformationmigrationmouse modelnotch proteinnoveloverexpressionpermissivenesspreventpreventive interventionprogenitorprogramsrestorationsynergismwhole genome
项目摘要
PROJECT SUMMARY/ABSTRACT
Nearly 30% of patients with Fetal Alcohol Spectrum Disorder (FASD) have a congenital heart defect
(CHD). Outflow tract (OFT) defects are over-represented, though with variable incidence and severity. The
majority of prenatal alcohol exposure (PAE) research focuses on the hallmarks of FASD, chronic drinking and
neurologic defects. The most common form of PAE in the population, acute exposure during the
periconceptual period, and its effect on cardiac development have not been studied. We will study the effects
of acute, periconceptual drinking both through a multi-institutional clinical study and with our acute PAE murine
model, in which mice receive two intraperitoneal injections of 3g/kg of 30% ethanol at a point critical to cardiac
organogenesis. We hypothesize the variable incidence and severity of PAE-induced OFT defects can be
explained by a combination of PAE and otherwise non-deleterious mutations that result in a genetically
permissive background. We believe mutations in the Notch pathway establish such a genetically permissive
background, and that PAE acts synergistically with these mutations via epigenetic regulation of Notch to result
in OFT malformation. Aim 1 of this study will address the specificity of the deleterious effects of PAE to OFT
alignment and define the molecular pathways disrupted in individuals with PAE-induced OFT defects. We will
achieve this through relative risk analysis of PAE and CHD diagnoses and pathway and subsequent logistical
regression analyses of whole genome sequencing data. Aim 2 will define alcohol driven epigenetic regulation
as the mechanism by which acute PAE and otherwise non-deleterious Notch pathway mutations synergistically
disrupt OFT development. Using a combination of molecular assays and histologic analysis in vitro and in vivo,
we will test the impact of this combined teratogenic insult on second heart field (SHF) viability and ability to
migrate into the OFT. We will establish PAE driven epigenetic regulation, disrupting Notch gene accessibility
and transcription, inhibits Notch signaling and use a pan-histone acetyltransferase inhibitor in vitro to
demonstrate prevention of PAE induced hyperacetylation is sufficient to rescue Notch signaling and SHF
viability. Similarly, rescue of SHF viability by overexpression of notch intracellular domain (NICD) in vitro will
cement the point of acute PAE and Notch mutation synergy as loss of Notch signaling prohibiting SHF viability.
As one of the first studies to examine the interaction of clinically relevant acute PAE with heart
development, this study addresses the priorities of the NIAAA to define the impact of non-chronic exposure
and alcohol’s effects on understudied organ systems. The genetic pathways identified by this study, including
novel validation of the Notch pathway as significant in PAE-induced CHD, will provide targets for disease
prevention and identification of those most at risk to develop the world’s most common and deadly birth defect.
Completion of this project is ensured by the technical training and mentorship by the sponsorship team, the
training site’s cutting-edge facilities, and education provided by the principal investigator’s M.D.-Ph.D. program.
项目概要/摘要
近 30% 的胎儿酒精谱系障碍 (FASD) 患者患有先天性心脏缺陷
(CHD) 流出道 (OFT) 缺陷的比例较高,但其发生率和严重程度各不相同。
大多数产前酒精暴露 (PAE) 研究重点关注胎儿酒精谱系障碍 (FASD)、长期饮酒和
神经系统缺陷是人群中最常见的 PAE 形式,是在急性暴露期间发生的。
围孕期及其对心脏发育的影响尚未研究。我们将研究其影响。
通过多机构临床研究和我们的急性 PAE 小鼠对急性围孕期饮酒的影响
模型中,小鼠在心脏功能关键点接受两次腹腔注射 3g/kg 30% 乙醇
我们探讨了 PAE 引起的 OFT 缺陷的不同发生率和严重程度。
PAE 和其他非有害突变的组合可以解释这一点,这些突变会导致基因突变
我们相信Notch通路的突变建立了这样的遗传许可。
PAE 通过 Notch 的表观遗传调控与这些突变协同作用,从而产生
本研究的目标 1 将解决 PAE 对 OFT 有害影响的特异性。
我们将对齐并定义 PAE 引起的 OFT 缺陷个体中被破坏的分子途径。
通过 PAE 和 CHD 诊断和途径的相对风险分析以及后续的后勤保障来实现这一目标
目标 2 将定义酒精驱动的表观遗传调控
作为急性 PAE 和其他非有害 Notch 途径突变协同作用的机制
结合体外和体内分子测定和组织学分析,破坏 OFT 发育。
我们将测试这种联合致畸损伤对第二心脏区 (SHF) 活力和能力的影响
我们将建立 PAE 驱动的表观遗传调控,破坏 Notch 基因的可及性。
和转录,抑制 Notch 信号传导,并在体外使用泛组蛋白乙酰转移酶抑制剂
证明预防 PAE 诱导的过度乙酰化足以挽救 Notch 信号传导和 SHF
同样,通过在体外过度表达缺口胞内结构域(NICD)来挽救 SHF 的活力。
巩固急性 PAE 和 Notch 突变协同作用的观点,因为 Notch 信号传导的丧失会抑制 SHF 的生存能力。
作为首批研究临床相关急性 PAE 与心脏相互作用的研究之一
发展,本研究解决了 NIAAA 的优先事项,以确定非慢性暴露的影响
和”酒精对尚未研究的器官系统的影响,包括本研究确定的遗传途径。
Notch 通路在 PAE 诱发的冠心病中具有重要意义的新验证将为疾病提供靶标
预防和识别那些最有可能患上世界上最常见和致命的出生缺陷的人。
赞助团队的技术培训和指导确保了该项目的完成
培训中心的尖端设施以及首席研究员的医学博士项目提供的教育。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Drayton C Harvey其他文献
Delta‐like ligand‐4 regulates Notch‐mediated maturation of second heart field progenitor‐derived pharyngeal arterial endothelial cells
Delta样配体-4调节Notch介导的第二心区祖细胞来源的咽动脉内皮细胞的成熟
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:5.3
- 作者:
Prashan De Zoysa;O. Toubat;Drayton C Harvey;Christopher Yi;Jiang Liu;S. Cavallero;Young;H. Sucov;Subramanyan Ram Kumar - 通讯作者:
Subramanyan Ram Kumar
Drayton C Harvey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Drayton C Harvey', 18)}}的其他基金
Acute Prenatal Alcohol Exposure Potentiates Conotruncal Defects in the Setting of a Permissive Genetic Background
在允许的遗传背景下,急性产前酒精暴露会加剧圆锥干缺陷
- 批准号:
10536511 - 财政年份:2022
- 资助金额:
$ 5.27万 - 项目类别:
相似国自然基金
肠道菌群短链脂肪酸代谢物通过组蛋白去乙酰化酶HDAC2/ELK1通路调控模拟失重下成骨细胞分化和骨形成的机制研究
- 批准号:82302112
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于乙酰化修饰探究支链氨基酸调控大口黑鲈肝脏脂代谢的分子机制
- 批准号:32303023
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于二十二碳五烯酸介导HADHA乙酰化研究芪参活血方治疗脓毒症心肌损伤的“益气”增效机制
- 批准号:82374069
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
脂肪酸β氧化介导ALKBH5乙酰化促进三阴性乳腺癌干细胞免疫逃逸的作用及机制研究
- 批准号:82373088
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于ChREBP乙酰化介导脂肪酸代谢探讨“肝病及心”理论内涵及降脂消斑方干预研究
- 批准号:82374192
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Roles of Chromatin Remodeler CHD2 in Diffuse Midline Glioma with Onco-Histone Mutations
染色质重塑蛋白 CHD2 在具有癌组蛋白突变的弥漫性中线胶质瘤中的作用
- 批准号:
10667276 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
The Role of Microbiome Composition in Amphetamine Abuse
微生物组组成在安非他明滥用中的作用
- 批准号:
10656799 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10600887 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
Restore the Tumor-Suppressive Activities of p53 Mutants
恢复 p53 突变体的肿瘤抑制活性
- 批准号:
10716397 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别:
Cofactor metabolism and mitochondrial function in malaria parasites
疟原虫的辅因子代谢和线粒体功能
- 批准号:
10659968 - 财政年份:2023
- 资助金额:
$ 5.27万 - 项目类别: